Gold price today: Yellow metal off from highs; likely to trade in Rs 43,000-43,650 range

Equity markets tumbled in India and across the globe, the rupee fell 60 paise to a dollar and gold traded flat after WHO declared the coronavirus outbreak a pandemic.

Kshitij Anand

March 12, 2020 / 10:15 IST

India's gold prices for April retreated on March 12 but the precious metal is expected to hold on to the crucial support placed at Rs 43,000.

Equity markets tumbled in India and across the globe, the rupee fell more than 60 paise against the dollar and gold traded flat after the World Health Organization declared the coronavirus outbreak a pandemic.

The previous day, gold had slipped below $1,640 per troy ounce and silver also tested $16.70 per troy ounce. Prices in the domestic market tested crucial support of Rs 44,330 for gold and silver prices also tested lows of Rs 45,719.

On March 12 the Multi Commodity Exchange (MCX), April gold contracts were trading lower by Rs 47, or 0.11 percent, at Rs 43,308 per 10 gram at 1000 hours.

“The strength in the rupee prices of both the precious metals shows weakness in the domestic market on Wednesday. The WHO declared Covid-19 as pandemic and global equities slides again despite interest rates cut by Bank of England and stimulus hope from the US, we expect both the precious metals to remain volatile,” said Manoj Jain, Director, IndiaNivesh Commodities.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show

Gold price today: Yellow metal off from highs; likely to trade in Rs 43,000-43,650 range

Equity markets tumbled in India and across the globe, the rupee fell 60 paise to a dollar and gold traded flat after WHO declared the coronavirus outbreak a pandemic.

Related stories

Trending news